European Commission approves label expansion of Roche’s Hemlibra to include people with moderate haemophilia A in the EU February 1, 2023February 1, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: CHMP recommends expansion of EU label for Hemlibra…Interim data from phase III HAVEN 6 study…New data from phase III HAVEN 6 study reinforce…European Commission approves Roche’s Tecentriq as…European Commission approves Roche’s first-in-class…New data reinforce the benefit of early preventative…
